Leading Life Science Innovation
Discover the future of omics with MGI's Next-Generation Sequencing: ultra-high throughput, scalability, and speed. Enhance your research with precision sequencing, advanced automation, and integrated bioinformatics, expanding the possibilities in genomics.
Leading with innovation to all Sequencing Industry Explorers
Sequencing platforms
Maximize your sequencing projects with DNBSEQ™, delivering superior accuracy and efficiency for all genomic research.
Laboratory automation
Our scalable lab automation systems ensure adaptability, supporting applications from diagnostics to genomics.
Bioinformatics software
Advanced tools and sequencing technologies drive insights into genetics, empowering multiomics breakthroughs.
Novel Products
Unlock precision with DNBSEQ™ chemistry, NGS, Stereo-Seq, and Single-cell platforms for seamless integration in genetic studies.
Operating in 100+ countries with 2,900+ users, MGI's technology supports 781+ valid patent applications and over 60 petabytes of data generation with T series sequencers.
Employees Worldwide, including 33.4% in R&D, with 9 R&D centers, 7 production centers, and 10+ CEC labs.
Papers published in top scientific journals, including 900+ in CNS, Lancet, and other core journals based on the DNBSEQ platform.
In the science journal
Detection of Drug-Resistant Mycobacterium tuberculosis Using ELITe InGenius® and MGI ATOPlex Technology
Mycobacterium tuberculosis detection
Nov 26, 2024
Explore advanced detection of drug-resistant Mycobacterium tuberculosis mutations using ELITe InGenius® and MGI ATOPlex DNBSEQ™ technologies for faster, more accurate diagnosis.
